Denali Therapeutics Inc (DNLI) — Free Cash Flow Generation Index
Denali Therapeutics Inc (DNLI) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $512.72 Million represents 1% of operating cash flow ($513.91 Million). Read DNLI current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Denali Therapeutics Inc Free Cash Flow Generation Index (2018–2020)
Historical FCF Generation Index trend for Denali Therapeutics Inc across 2 annual periods. Explore Denali Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Denali Therapeutics Inc (2018–2020)
Year-by-year Free Cash Flow Generation Index for Denali Therapeutics Inc. For the full company profile including market capitalisation, see Denali Therapeutics Inc (DNLI) market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.99x | $413.06 Million | $416.15 Million | $3.10 Million | ▲ +6.5% |
| 2018 | 0.93x | $46.72 Million | $50.12 Million | $3.39 Million | — |